Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$478.54M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$481.33M
Operating Margin
-43.75%
TTM Avg
-69.37%
3Y Avg
-212.63%
5Y Avg
-278.07%
Market Cap
$471.57M
Operating Margin
-0.73%
TTM Avg
-6.05%
3Y Avg
-13.09%
5Y Avg
-25.54%
Market Cap
$487.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$491.55M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
Market Cap
$491.93M
Operating Margin
-7.33%
TTM Avg
-12.79%
3Y Avg
-23.47%
5Y Avg
-68.20%
Market Cap
$453.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $478.54M | 0.00% | 0.00% | 0.00% | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | -43.75% | -69.37% | -212.63% | -278.07% |
| Cerus Corporation (CERS)vs › | $471.57M | -0.73% | -6.05% | -13.09% | -25.54% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| NRC Health (NRC)vs › | $468.31M | 10.53% | 20.52% | 24.67% | 27.45% |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | -8.63% | -11.52% | -18.04% | -16.64% |
| Evolus, Inc. (EOLS)vs › | $491.93M | -7.33% | -12.79% | -23.47% | -68.20% |
| Kamada Ltd. (KMDA)vs › | $461.55M | 14.51% | 13.50% | 9.39% | 8.55% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | -11.75% | -88.01% | -269.63% | -547.01% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 77.87% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
